NantHealth Strengthens Product Leadership Team to Drive Innovation in Healthcare Technology
10 Abril 2024 - 10:00AM
Business Wire
NantHealth, Inc. (NASDAQ-GS: NH), proudly announces the
expansion of its product leadership team by appointing three
seasoned executives who will spearhead efforts to integrate
innovation, automation, and artificial intelligence into the
company's product offerings. This strategic move underscores
NantHealth's unwavering commitment to revolutionizing healthcare
technology and delivering excellence to its customers.
Keith Krebs - Senior Vice President and General Manager,
Eviti
Keith Krebs is appointed as the Senior Vice President and
General Manager for the Eviti Connect product line, bringing a
wealth of experience in driving innovation and customer
satisfaction. With a remarkable track record in leadership roles
spanning implementations, client services and product development,
Krebs is poised to lead the charge in leveraging artificial
intelligence and automation to enhance the Eviti platform's
capabilities.
Sean Henson - Senior Vice President and General Manager,
NaviNet
Sean Henson assumes the role of Senior Vice President and
General Manager for NaviNet a leading payer-provider collaboration
platform, facilitating provider engagement and generating
actionable data throughout the continuum of care delivery. With
over a decade of expertise in value-based care performance and
analytics, Henson is committed to leveraging advanced technologies
to optimize patient care quality and cost-effectiveness within the
NaviNet platform.
Alan Brown - Senior Vice President and General Manager,
OpenNMS
Alan Brown joins NantHealth as the Senior Vice President and
General Manager of the OpenNMS product line, responsible for
overseeing the world's first full open-source enterprise-grade
network service monitoring. With over 30 years of experience in
Aerospace & Defense and Telecommunication industries, Brown is
dedicated to driving innovation and efficiency through strategic
business vision and results-driven tactical execution.
NantHealth's recent appointments emphasize the company's
strategic commitment to integrating innovation, automation, and
artificial intelligence into its product development process. With
a leadership team that possesses a deep understanding of industry
dynamics and a strong drive to effect positive change, NantHealth
is well-positioned to consistently deliver cutting-edge products
and services that cater to the evolving needs of its customers.
“We are excited to welcome Keith, Sean, and Alan to our
leadership team,” said Lauren Schiegg, Chief Operating Officer at
NantHealth. “Their extensive experience and visionary leadership
will play a crucial role in accelerating our efforts to innovate
and drive positive transformation in the healthcare technology
landscape. Together, we are committed to delivering unparalleled
value to our customers and revolutionizing healthcare for the
better.”
About NantHealth, Inc.
NantHealth, a member of the NantWorks ecosystem of companies,
provides enterprise solutions that help businesses transform
complex data into actionable insights. By offering efficient ways
to move, interpret and visualize complex and highly sensitive
information, NantHealth enables customers in healthcare, life
sciences, logistics, telecommunications and other industries to
automate, understand and act on data while keeping it secure and
scalable. NantHealth’s product portfolio comprises the latest
technology in payer-provider collaboration platforms for real-time
coverage, decision support and data solutions that provide
multi-data analysis, reporting and professional services offerings.
For more information, visit nanthealth.com, follow us on Twitter,
Facebook, LinkedIn and YouTube and subscribe to our blog.
Forward Looking Statements
This news release contains certain statements of a
forward-looking nature relating to future events or future business
performance. Forward-looking statements can be identified by the
words “expects,” “anticipates,” “believes,” “intends,” “estimates,”
“plans,” “will,” “outlook” and similar expressions. Forward-looking
statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are
made. Risks and uncertainties include, but are not limited to,
statements regarding the timing and effectiveness of the reverse
stock split and the Company’s ability to maintain its listing on
Nasdaq (including its ability to achieve or maintain the minimum
bid price required by Nasdaq and to comply with other requirements
for listing on Nasdaq). Such forward-looking statements are not
meant to predict or guarantee actual results, performance, events
or circumstances and may not be realized because they are based
upon the Company’s current plans, objectives, beliefs,
expectations, and assumptions and are subject to a number of risks
and uncertainties and other influences, many of which the Company
has no control over. Actual results and the timing of certain
events and circumstances may differ materially from those described
by the forward-looking statements as a result of these risks and
uncertainties. Factors that may influence or contribute to the
inaccuracy of the forward-looking statements or cause actual
results to differ materially from expected or desired results may
include, without limitation, the price and volume fluctuations in
trading of the Company’s Common Stock, the potential adverse effect
of the reduced number of shares outstanding following the reverse
stock split on the liquidity of the Company’s Common Stock,
potentially adverse Nasdaq decisions related to the listing of the
Company’s Common Stock on the Nasdaq Capital Market. The Company
undertakes no obligation to update any forward-looking statement in
light of new information or future events, except as otherwise
required by law. Forward-looking statements involve inherent risks
and uncertainties, most of which are difficult to predict and are
generally beyond our control. Actual results or outcomes may differ
materially from those implied by the forward-looking statements as
a result of the impact of a number of factors, many of which are
discussed in more detail in our reports filed with the Securities
and Exchange Commission.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240410753567/en/
Jen Hodson NantWorks 562-397-3639 jen@nant.com
NantHealth (NASDAQ:NH)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
NantHealth (NASDAQ:NH)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024